Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 796

1.

Medical marijuana: more questions than answers.

Hill KP.

J Psychiatr Pract. 2014 Sep;20(5):389-91. doi: 10.1097/01.pra.0000454786.97976.96.

PMID:
25226202
[PubMed - in process]
2.

Sy14-2management of medical consequences of cannabis: research at national institute on drug abuse.

Khalsa JH.

Alcohol Alcohol. 2014 Sep;49 Suppl 1:i14. doi: 10.1093/alcalc/agu052.62.

PMID:
25221011
[PubMed - in process]
3.

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications.

Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA.

Drug Alcohol Depend. 2014 Aug 18. pii: S0376-8716(14)01033-3. doi: 10.1016/j.drugalcdep.2014.08.005. [Epub ahead of print] Review.

PMID:
25220897
[PubMed - as supplied by publisher]
4.

Ischaemic conditioning strategies reduce ischaemia/reperfusion-induced organ injury.

Pac-Soo CK, Mathew H, Ma D.

Br J Anaesth. 2014 Sep 12. pii: aeu302. [Epub ahead of print] Review.

PMID:
25216929
[PubMed - as supplied by publisher]
5.

Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting.

Santana TA, Trufelli DC, de Matos LL, Cruz FM, Del Giglio A.

Support Care Cancer. 2014 Aug 22. [Epub ahead of print]

PMID:
25145507
[PubMed - as supplied by publisher]
6.

Cannabinoids as therapeutic agents in cancer: current status and future implications.

Chakravarti B, Ravi J, Ganju RK.

Oncotarget. 2014 Aug 15;5(15):5852-72.

PMID:
25115386
[PubMed - in process]
Free PMC Article
7.

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1.

Haustein M, Ramer R, Linnebacher M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Jul 25. pii: S0006-2952(14)00420-1. doi: 10.1016/j.bcp.2014.07.014. [Epub ahead of print]

PMID:
25069049
[PubMed - as supplied by publisher]
8.

Advances in transient receptor potential vanilloid-2 channel expression and function in tumor growth and progression.

Liberati S, Morelli MB, Amantini C, Santoni M, Nabissi M, Cardinali C, Santoni G.

Curr Protein Pept Sci. 2014;15(7):732-7.

PMID:
25001513
[PubMed - in process]
9.

Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells.

Ramer R, Fischer S, Haustein M, Manda K, Hinz B.

Biochem Pharmacol. 2014 Sep 15;91(2):202-16. doi: 10.1016/j.bcp.2014.06.017. Epub 2014 Jun 26.

PMID:
24976505
[PubMed - in process]
10.

Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.

Moreno E, Andradas C, Medrano M, Caffarel MM, Pérez-Gómez E, Blasco-Benito S, Gómez-Cañas M, Pazos MR, Irving AJ, Lluís C, Canela EI, Fernández-Ruiz J, Guzmán M, McCormick PJ, Sánchez C.

J Biol Chem. 2014 Aug 8;289(32):21960-72. doi: 10.1074/jbc.M114.561761. Epub 2014 Jun 18.

PMID:
24942731
[PubMed - in process]
11.

Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.

Murase R, Kawamura R, Singer E, Pakdel A, Sarma P, Judkins J, Elwakeel E, Dayal S, Martinez-Martinez E, Amere M, Gujjar R, Mahadevan A, Desprez PY, McAllister SD.

Br J Pharmacol. 2014 Oct;171(19):4464-77. doi: 10.1111/bph.12803. Epub 2014 Sep 5.

PMID:
24910342
[PubMed - in process]
12.

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation.

Hermanson DJ, Gamble-George JC, Marnett LJ, Patel S.

Trends Pharmacol Sci. 2014 Jul;35(7):358-67. doi: 10.1016/j.tips.2014.04.006. Epub 2014 May 18. Review.

PMID:
24845457
[PubMed - indexed for MEDLINE]
13.

Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.

Davis MP.

Expert Opin Investig Drugs. 2014 Aug;23(8):1123-40. doi: 10.1517/13543784.2014.918603. Epub 2014 May 16.

PMID:
24836296
[PubMed - in process]
14.

Effects of 20 mg oral Δ9 -tetrahydrocannabinol on the olfactory function of healthy volunteers.

Walter C, Oertel BG, Ludyga D, Ultsch A, Hummel T, Lötsch J.

Br J Clin Pharmacol. 2014 May 6. doi: 10.1111/bcp.12415. [Epub ahead of print]

PMID:
24802974
[PubMed - as supplied by publisher]
15.

Neuropathic cancer pain: What we are dealing with? How to manage it?

Esin E, Yalcin S.

Onco Targets Ther. 2014 Apr 17;7:599-618. doi: 10.2147/OTT.S60995. eCollection 2014. Review.

PMID:
24790459
[PubMed]
Free PMC Article
16.

Should doctors prescribe cannabinoids?

Farrell M, Buchbinder R, Hall W.

BMJ. 2014 Apr 23;348:g2737. doi: 10.1136/bmj.g2737. No abstract available.

PMID:
24760158
[PubMed - indexed for MEDLINE]
17.

Novel method of determination of D9-tetrahydrocannabinol(THC) in human serum by high-performance liquid chromatography with electrochemical detection.

Kokubun H, Uezono Y, Matoba M.

Gan To Kagaku Ryoho. 2014 Apr;41(4):471-3.

PMID:
24743363
[PubMed - indexed for MEDLINE]
18.

[Therapeutic use of cannabis derivatives].

Benyamina A, Reynaud M.

Rev Prat. 2014 Feb;64(2):165-8. French.

PMID:
24701869
[PubMed - indexed for MEDLINE]
19.

WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation.

Pellerito O, Notaro A, Sabella S, De Blasio A, Vento R, Calvaruso G, Giuliano M.

Apoptosis. 2014 Jun;19(6):1029-42. doi: 10.1007/s10495-014-0985-0.

PMID:
24696378
[PubMed - in process]
20.

Investigation of the in vitro toxicological properties of the synthetic cannabimimetic drug CP-47,497-C8.

Koller VJ, Auwärter V, Grummt T, Moosmann B, Mišík M, Knasmüller S.

Toxicol Appl Pharmacol. 2014 Jun 1;277(2):164-71. doi: 10.1016/j.taap.2014.03.014. Epub 2014 Mar 28.

PMID:
24686252
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk